Licensing Revenue. Subsequent to any Program Transfer, IMDZ shall pay to Sanofi *** Licensing Revenue *** as follows: Program Transfer *** *** Licensing Revenue *** *** *** *** *** ***
Licensing Revenue. Section 1.72 (“Sublicensing Revenue”) is hereby made reciprocal and shall apply to consideration received by Kirin or its Affiliates. In the event that Kirin or its Affiliate grants a Third Party a license or sublicense in the Aveo Territory to a Licensed Product outside the Field as newly redefined in Section 1.30 of the Agreement, Kirin shall pay to Aveo [**]% of the Sublicensing Revenue received by Kirin or its Affiliate from such Third-Party. Such payment shall be payable quarterly, within [**] after the end of the calendar quarter in which Kirin or its Affiliate receives the underlying such payment.
Licensing Revenue. 5.1 UMB shall use reasonable efforts to collect all material amounts due under the Tokai MLA with respect to the Joint Invention. UMB shall calculate: (a) the amount of Gross Income; (b) the amount of each party’s unreimbursed Patent Expenses, (c) the Administrative Fee, and (d) Net Revenues. UMB shall provide a written report of its calculations to TJU and UMES periodically, but no less often than annually. TJU and UMES shall review those calculations and shall notify UMB of any discrepancies within fifteen (15) days after receipt of that report.
Licensing Revenue. (a) During the Royalty Term, Purchaser will pay to Fresh Cut or its designee [*]% of all Licensing Revenue (or the allocable portion of Licensing Revenue determined in accordance with Section 3.3(b)) actually received by Purchaser or its Affiliates. Such amounts shall be paid on a Calendar Quarterly basis concurrent with the payment of the Royalties.
Licensing Revenue. Subject to the provisions of Section 10.6 below, in the event Buyer enters into an agreement licensing to a Third Party some or all of the Patent Rights granted to it pursuant to Section 2.1 hereof, Buyer shall pay to Seller 10% of all up-front fees, milestones, running royalties and other economic consideration received by Buyer from such Third Party.
Licensing Revenue. Artist shall receive no revenue generated from Publisher's licensing activities, except as part of the payments set forth above.
Licensing Revenue. SB or Incyte, as the case may be, shall pay DiaDexus ****** percent of Licensing Revenue for DiaDexus Patents licensed to Third Parties in the field of Rx/Other, only where such license is in the absence of the grant of rights to an Rx Product and payment of royalties and other payments to DiaDexus pursuant to subparagraphs (a)-(e).
